argenx SE ARGX
905.66 USD +4.54 (+0.50%)
Nov 4, 2026, 10:40 AM EST
895.49 Day range 922.94
663.93 52-week range 1,058.90
- YTD
- +7.69%
- 1 year
- +8.92%
Analyst view
Consensus: buy
Buy
Price target (mean) 1,147.35 +26.7% upside
Now 905.66
- Target (low)
- 861.00
- Target (mean)
- 1,147.35
- Target (high)
- 1,353.00
Ratings (0m) 23 20 buy · 3 hold · 0 sell
- Strong buy7
- Buy13
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 23
- 1 month ago 23
- 2 months ago 25
- 3 months ago 25
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 7.32 | 6.56 – 8.08 | 8.02 | -8.7% | 1.89B | +43.1% | 2 |
| Next quarter | 6.49 | 6.49 – 6.49 | 5.52 | +17.6% | 1.85B | +41.2% | 1 |
| Current year | 28.28 | 27.16 – 29.45 | 19.57 | +44.5% | 6.42B | +51.1% | 4 |
| Next year | 33.31 | 31.68 – 34.74 | 28.28 | +17.8% | 7.87B | +22.6% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 23, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 23, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 23, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 23, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 23, 2026 | Baird | Maintained | Neutral | Neutral |
| Oct 20, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 14, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 9, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 9, 2026 | Baird | Maintained | Neutral | Neutral |
| Sep 8, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Sep 3, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 31, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 26, 2026 | UBS | Upgrade | Neutral | Buy |
| Aug 26, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 18, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 18, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 18, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 18, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 18, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 18, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 17, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 28, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 27, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 24, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 24, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 24, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 24, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 21, 2026 | Citigroup | Maintained | Buy | Buy |
